UBS AM’s BioSpecifics Technologies Corp. BSTC Stock Holding History

UBS AM’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,300	Closed	-$204K	–	2638
2020 Q4	$204K	Buy	+2,300	New	+$184K	﹤0.01%	2501

UBS AM's BSTC Position: Q1 2021 in Review

UBS AM sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2021, closing a stake of 2,300 shares — an estimated $204K sold.

UBS AM first reported a position in BSTC in Q4 2020 and held it in 1 quarter. The position peaked at $204K in Q4 2020. 0 funds tracked by Wall St. Rank hold BSTC as of Q1 2021.

UBS AM reported no remaining BioSpecifics Technologies Corp. position as of Q1 2021 after selling out during the quarter.
UBS AM sold 2,300 BioSpecifics Technologies Corp. shares in Q1 2021, an estimated $204K.
UBS AM first reported a position in BioSpecifics Technologies Corp. in Q4 2020 and held it in 1 quarter.
UBS AM's BioSpecifics Technologies Corp. position peaked at $204K in Q4 2020.
0 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2021.

Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.